T3 Pharmaceuticals

Illustration connected puzzle pieces with the acronym MA

Biotech

Boehringer buys bacterial cancer therapy biotech in $500M deal

Boehringer Ingelheim is acquiring bacterial cancer therapy company T3 Pharmaceuticals in a deal that could be worth up to $508M.

Gabrielle Masson Nov 22, 2023 10:21am

Swiss flag by a lake

Boehringer backs T3 to take bacterial cancer therapy into clinic

Jul 22, 2020 7:55am